# Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections

> **NCT03397914** · PHASE4 · COMPLETED · sponsor: **National Cancer Institute, Egypt** · enrollment: 70 (actual)

## Conditions studied

- Gram-Negative Bacterial Infections
- Pediatric Cancer
- Colistin
- Colistin Adverse Reaction
- MIC

## Interventions

- **DRUG:** Colistimethate Sodium

## Key facts

- **NCT ID:** NCT03397914
- **Lead sponsor:** National Cancer Institute, Egypt
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2019-01
- **Final completion:** 2019-03
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2020-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03397914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03397914, "Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03397914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*